Hailey Biotech (603718.SH) released its 2023 annual report, achieving revenue of 241 million yuan, a year-on-year decrease of 19.76%. Net profit attributable to shareholders of listed companies was 62.882 million yuan, a year-on-year decrease of 48.30%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 11.8219 million, a year-on-year decrease of 52.36%. It is proposed to distribute a cash dividend of 0.287 yuan (tax included) for every 10 shares to all shareholders.
海利生物(603718.SH)发2023年业绩，净利润6287.02万元，同比下降48.30%
Hailey Biotech (603718.SH) reported 2023 results, net profit of 62.882 million yuan, a year-on-year decrease of 48.30%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.